S&P 500
(0.34%) 5 117.08 points
Dow Jones
(0.34%) 38 368 points
Nasdaq
(0.38%) 15 989 points
Oil
(-0.95%) $83.05
Gas
(5.25%) $2.02
Gold
(0.34%) $2 355.10
Silver
(0.50%) $27.67
Platinum
(4.12%) $960.05
USD/EUR
(-0.28%) $0.932
USD/NOK
(-0.46%) $10.97
USD/GBP
(-0.58%) $0.796
USD/RUB
(1.66%) $93.40

リアルタイムの更新: Conformis Inc [CFMS]

取引所: NASDAQ セクター: Healthcare 産業: Medical Devices
最終更新日時2 9月 2023 @ 04:57

0.44% $ 2.27

Live Chart Being Loaded With Signals

Commentary (2 9月 2023 @ 04:57):
Profile picture for Conformis Inc

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products...

Stats
本日の出来高 7 081.00
平均出来高 156 850
時価総額 17.88M
EPS $0 ( 2024-02-28 )
次の収益日 ( $0 ) 2024-05-06
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.398
ATR14 $0.0220 (0.97%)
Insider Trading
Date Person Action Amount type
2023-09-05 Desrochers Christine Sell 81 465 Common Stock
2023-09-05 Augusti Mark A Buy 17 778 Common Stock
2023-09-05 Augusti Mark A Sell 190 277 Common Stock
2023-09-05 Bienkowski Carrie Sell 19 909 Common Stock
2023-09-05 Fischetti Gary P Sell 10 470 Common Stock
INSIDER POWER
18.90
Last 95 transactions
Buy: 11 050 651 | Sell: 1 697 895

ボリューム 相関

長: 0.07 (neutral)
短: 0.00 (neutral)
Signal:(73.933) Neutral

Conformis Inc 相関

10 最も正の相関
ENNV0.952
MAGS0.949
TSHA0.948
NVTSW0.947
PIXY0.947
AHPI0.943
GSMG0.942
MDXH0.94
SRNGW0.938
LSAQ0.938
10 最も負の相関
NVCN-0.971
FOCS-0.961
HHGC-0.957
ITI-0.957
ACLS-0.956
ALGM-0.954
ECHO-0.953
BWMN-0.951
IIN-0.951
TETC-0.949

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Conformis Inc 相関 - 通貨/商品

The country flag -0.37
( neutral )
The country flag 0.36
( neutral )
The country flag 0.00
( neutral )
The country flag -0.17
( neutral )
The country flag 0.78
( moderate )
The country flag 0.31
( neutral )

Conformis Inc 財務諸表

Annual 2022
収益: $62.05M
総利益: $23.21M (37.41 %)
EPS: $-6.99
FY 2022
収益: $62.05M
総利益: $23.21M (37.41 %)
EPS: $-6.99
FY 2021
収益: $99.86M
総利益: $65.68M (65.77 %)
EPS: $-0.362
FY 2020
収益: $68.76M
総利益: $33.72M (49.03 %)
EPS: $-8.47

Financial Reports:

No articles found.

Conformis Inc

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruciate retaining total knee replacement product; iTotal PS, a posterior stabilized knee replacement product, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。